Navigation Links
Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
Date:2/7/2011

RICHMOND, Calif., Feb. 7, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 2:30 pm ET on Monday, February 14, 2011 at the 13th Annual BIO CEO & Investor Conference which will be held in New York City.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo

Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and modification.  The most advanced ZFP Therapeutic® development program is currently in a Phase 2b clinical trial for evaluation of safety and clinical effect in patients with diabetic neuropathy and a Phase 2 trial in ALS. Sangamo also has a Phase 1/2 clinical trial and two ongoing Phase 1 clinical trials to evaluate safety and clinical effect of a treatment for HIV/AIDS as well as a Phase 1 trial of a treatment for recurrent glioblastoma multiforme. Other therapeutic development programs are focused on Parkinson's disease, monogenic diseases, neuropathic pain and nerve regeneration.  Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.  Sangamo is also developi
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
2. Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference
3. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
4. Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinsons Disease
5. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
6. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
7. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
8. Sangamo Announces Closing of Common Stock Offering
9. Sangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
10. Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
11. Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the CL King 12 ... September 9, 2014 at 12:30 p.m. ET. The conference ... in New York City . ...
(Date:8/29/2014)... 29, 2014 , Industry ... the inaugural Tweetchat taking place in real-time at ... organised by UBM Live , announces the ... a first of its kind global industry-wide Tweetchat ... supply chain, aimed to stimulate conversations on key ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces that ... in its catalogue: Needle-Free Delivery: ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html Report ... and commercial prospects What does the future ... brand new report shows you the potential ...
Breaking Medicine Technology:Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
... 15, 2007 /PRNewswire/ -- Solstice,Neurosciences, Inc. today reported ... of Botulinum Toxin Type B,Injectable Solution (Myobloc(R)) recently ... Disorders Society in,Istanbul, Turkey. , This was the ... of escalating treatment doses of 10,000 Units, 12,500,Units, ...
... Survival Benefit Demonstrated for an AI Over Tamoxifen ... 15 June 2007: Analysis of the entire,population of ... breast cancer can be significantly improved by switching ... 95' (ARNO 95) study, published online in The,Journal ...
Cached Medicine Technology:Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 2Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 3Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5
(Date:8/29/2014)... August 30, 2014 Indosoft, Inc. ... software, announces the release of its most advanced contact ... number of new features as well as updates to ... , Q-Suite functionality on the presentation side has ... into the script builder. This WYSIWYG editor ...
(Date:8/29/2014)... AGH Healthy Happenings, a community education and ... at Atlantic General Hospital, are now offering area ... to no-cost blood pressure screenings at a local pharmacy, ... local sports tournaments. , In addition, the ... disease management and falls prevention workshops on various dates ...
(Date:8/29/2014)... Everyone dreams about looking absolutely great, ... , According to the latest review published by Daily ... imagined with the right tips and recommendations. , ... an amazingly effective and fast method of looking perfectly. ... program is really efficient when it comes to the ...
(Date:8/29/2014)... August 29, 2014 Daily Gossip reveals in its ... created by a former cold sores patient who suffered from this ... Ellie Gadsby, who decided to share her tips and advices, but ... , The author of the Get Rid of Cold Sores Fast ... years, while in the least 4 years outbreaks have become more ...
(Date:8/29/2014)... Daily Gossip reveals in its Stop Sciatica in ... of naturally curing this disease. , The program promises ... cure in only one week. This is described as a ... huge sacrifices. , Moreover, with this new method patients ... sciatica in just 8 minutes. , Interested customers can ...
Breaking Medicine News(10 mins):Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3Health News:Shapeshifter Yoga Review Reveals Kris Fondran's New Body Shaping and Fat Loss Program 2Health News:Get Rid of Cold Sores Fast Review Reveals Simple Way to Eliminate Cold Sores in 12 Hours 2Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2
... DIEGO, Oct. 19 RESMED INC. (NYSE: RMD ... will release its,earnings for this first quarter of fiscal ... earnings press release after 1:00 p.m. Pacific,Time and will ... trends, and future outlook. The conference call is ...
... woman, the less the idea bothered her , , FRIDAY, ... with the idea of childlessness than men, new research ... in how each gender views the pressures of parenthood. ... parenting and parenthood mean different things," said study author ...
... at home less likely to pass exams, research shows , ... smoke a threat to teen health, it can also affect ... at Temple University found that 16- and 18-year-olds exposed to ... pass standardized tests than their peers. , They reached this ...
... Fans Have Chance To Meet Newest Wings and Help Two Charitable Causes ... ... Oct. 19 The Red Wings support of two October,community initiatives will ... for the team,s smoke detector,collection initiative and the first annual Breast Cancer ...
... Oct. 19 PulseLearning,(which was founded in 1999 with ... a second-hand computer set up in a child,s bedroom ... fastest growing IT company in,Ireland at the ,2007 Deloitte ... now in their eighth year, rank the 50 fastest,growing ...
... Mary Remotti,feels when her body is touched by the even ... bed washes over her like the heat of an intense,fire. ... pain,which she cannot escape. Remotti is an 18-year-old Connecticut ... confined to her bed suffering from Reflex Sympathetic,Dystrophy (RSD) also ...
Cached Medicine News:Health News:ResMed to Webcast First Quarter 2008 Earnings Conference Call 2Health News:Childlessness Bothers Men More Than Women 2Health News:Childlessness Bothers Men More Than Women 3Health News:Secondhand Smoke Hurts Kids' Grades 2Health News:Drake, Rafalski to Sign Autographs at Hockeytown Authentics 2Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 2Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 3Health News:PulseLearning (Founded in Child's Bedroom in an Irish Suburban Semi Eight Years Ago and Initially Run on a Second-Hand Computer) Today Named Fastest Growing IT Company in Ireland 4Health News:Connecticut Girl Fights Rare Neurological Disease 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: